http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012147527-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65 |
| filingDate | 2011-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012147527-A |
| titleOfInvention | TETRACYCLINE COMPOSITION |
| abstract | 1. A medicament comprising an aqueous solution of minocycline and a divalent or trivalent cation in which the molar ratio of the divalent or trivalent cation to minocycline is more than 2: 1 and in which the solution does not include a pharmaceutically acceptable oil and which is suitable for intravenous administration2. A medicament comprising an aqueous solution of minocycline and a divalent or trivalent cation in which the molar ratio of the divalent or trivalent cation to minocycline is more than 2: 1 and in which the solution has a pH of more than 4 and less than 5 and which is suitable for intravenous administration. 3. A drug comprising an aqueous solution of the 7-dimethylamino-tetracycline antibiotic and a divalent or trivalent cation in which the molar ratio of the divalent or trivalent cation to the 7-dimethylamino-tetracycline antibiotic is more than 2: 1 and in which the solution does not include a pharmaceutically acceptable oil has a pH more than 4 and less than 7 and which is suitable for intravenous administration. 4. The medicine according to claims 1-3, wherein the solution does not include a component selected from the group consisting of polyoxyethylene hydrogenated castor oil, an antioxidant, a compound containing pyridine, nicotinamide, alcohol, glycerin, gluconate, a pyrrolidone compound, a local water-soluble anesthetic, procaine , urea, lactose and a dehydrating substance. 5. The medicament according to claims 1-3, wherein the solution does not include a dehydrating substance selected from the group consisting of ethyl acetate, acetic anhydride, absolute alcohol, ethyl acetate, acetic anhydride |
| priorityDate | 2010-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.